Results 51 to 60 of about 489,763 (264)
Early Impact of Childhood Opportunity on Neurocognitive Outcomes in Sickle Cell Disease
ABSTRACT Introduction Neurocognitive impairment is a well‐recognized complication of sickle cell disease (SCD) that begins early in childhood and persists across development. While cerebrovascular injury contributes substantially to risk, neurocognitive deficits are also observed in children without overt or silent cerebral infarctions, suggesting ...
Julia E. LaMotte +5 more
wiley +1 more source
ABSTRACT Background Pediatric bone sarcoma patients and survivors may experience psychosocial challenges related to childhood cancer after their intensive, body‐altering treatment. This cross‐sectional study aimed to evaluate generic and survivor‐specific psychosocial outcomes in a national cohort of pediatric bone sarcoma patients and survivors, and ...
Hinke van der Hoek +14 more
wiley +1 more source
The parametrization of orographic drag processes is a major source of circulation uncertainty in models. The COnstraining ORographic Drag Effects (COORDE) project makes a coordinated effort to narrow this uncertainty by bringing together the modeling ...
Annelize vanNiekerk +11 more
doaj +1 more source
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla +6 more
wiley +1 more source
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko +19 more
wiley +1 more source
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol +6 more
wiley +1 more source
ON NUMERICAL RADIUS INEQUALITIES FOR OPERATOR PRODUCTS IN HILBERT SPACES
We establish several numerical radius inequalities for products of two operators on a Hilbert space. Some of the obtained inequalities improve well-known results. More precisely, we show that if 𝐴, 𝐵 \in 𝐵(𝐻) double commute, then 𝑤(𝐴𝐵)
Ahmed Elbarbouchi +1 more
doaj +1 more source
On numerical range of sp(2n, C)
In this paper we studied the classical numerical range of matrices in sp(2n, C). We obtained some result on the relationship between the numerical range of a matrix in and that of its diagonal block, the singular values of its off-diagonal block A2.
Yan Wen, Tao Jicheng, Lu Zhao
doaj +1 more source
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens +4 more
wiley +1 more source
Numerical range of tensor product of operators in semi-Hilbert spaces
Let A and B be two positive bounded linear operators acting on the complex Hilbert spaces H and K, respectively. In this paper, we study the (A⊗B)-numerical range WA⊗B(T⊗S) of the tensor product T⊗S for two bounded linear operators T and S on H and K ...
doaj +1 more source

